What are the risks of Ibotenic acid?

The toxicity and long-term health effects of Ibotenic acid have not been comprehensively studied in scientific literature. The absence of evidence of harm is not evidence of absence — novel or under-researched substances may carry undocumented risks. General principles of toxicological concern apply

Ibotenic acid — SubstanceWiki

Ibotenic acid

3-Hydroxyisoxazole, Α-Amino acid · Hallucinogens

Hallucinogens(3-Hydroxyisoxazole, Α-Amino acid)

View full details

Naturally occurring glutamate receptor agonist neurotoxin

Ibotenic acid, or ibotenate, also known as premuscimol or as (S)-2-amino-2-(3-hydroxyisoxazol-5-yl)acetic acid, is a naturally occurring α-amino acid found in certain Amanita mushrooms such as Amanita muscaria. It acts primarily as a potent glutamate receptor agonist and produces neurological effects. The compound is used as a brain-lesioning agent in scientific research.

Ibotenic acid is a conformationally-restricted analogue of the excitatory neurotransmitter glutamate which acts as a non-selective agonist of glutamate receptors, strongly activating NMDA, group I and II metabotropic glutamate receptors, and weakly activating AMPA and kainate receptors. Taken systemically, it is a prodrug of muscimol, broken down by the liver into this more stable compound, which acts as a potent GABAA and GABAA-ρ receptor agonist. Although the compound's psychoactive effects are not well-understood, some researchers speculate that ibotenic acid itself may have stimulant-like properties. Ibotenic acid is biosynthesized from glutamic acid by hydroxylation catalyzed by an Fe(II)/2-oxoglutarate-dependent oxygenase, with subsequent conversion steps carried out by enzymes encoded within a linked biosynthetic gene cluster.

Ibotenic acid is commonly used in research to create site-specific hippocampal brain lesions in rats, allowing for task relearning due to its interaction with glutamate receptors, and is favored over other agents for its selectivity and long-term stability in saline solution. It induces excitotoxicity in rodents by overactivating NMDA and metabotropic glutamate receptors, leading to calcium overload and oxidative damage. In contrast, it targets glutamate-gated chloride channels in invertebrates, causing increased chloride permeability without affecting their excitatory glutamate receptors.

How It Feels

The onset of ibotenic acid, typically consumed as part of the Amanita muscaria mushroom, is a deeply disorienting process that bears little resemblance to the psychedelic experiences produced by psilocybin or LSD. Within thirty to ninety minutes of ingestion, a profound drowsiness begins to settle over the body, heavy and sedating in a way that feels more like encroaching illness than the beginning of a psychoactive experience. Nausea is common and often severe. There may be excessive salivation, sweating, and a general sense that the body's autonomic systems have been disrupted. Muscle twitching and fasciculations are reported, adding to the sense of physical disquiet.

As the experience deepens, the cognitive effects become apparent, and they are defined above all by confusion. This is not the meaningful confusion of a challenging psychedelic experience where the mind struggles with profound questions. It is a muddled, delirious confusion in which the ordinary organization of thought and perception begins to disintegrate. Spatial awareness becomes unreliable: rooms seem to grow and shrink, objects appear closer or farther than they are, and the sense of the body's position in space becomes precarious. There may be a strange macropsia or micropsia, where objects appear distorted in size, giving the environment an Alice-in-Wonderland quality that is more unsettling than enchanting.

At higher doses, the delirium deepens into a state that can resemble a waking dream. The boundary between internal imagery and external perception becomes porous, and the user may interact with hallucinations as though they were real, holding conversations with people who are not there or responding to events that exist only in the mind. Unlike the visionary content of classical psychedelics, these hallucinations are often mundane, confusing, and devoid of the numinous quality that users of other substances report. There may be periods of apparent lucidity followed by abrupt returns to confused, dreamlike states.

The experience typically lasts four to eight hours, with a prolonged period of grogginess, confusion, and physical discomfort as the effects recede. Sleep, when it arrives, is often heavy and populated with vivid, bizarre dreams. The morning after can bring lingering nausea, headache, and a sense of having been through something unpleasant without having gained anything from the ordeal. The overall character of ibotenic acid intoxication is one of pharmacological disorder, a disruption of normal functioning that lacks the insight, beauty, or emotional richness that makes other altered states sought after.

Full	Unknown
Half	Unknown
Zero	Unknown

Ibotenic acid

Dosage

Duration

How It Feels

Subjective Effects

Physical Effects

Physical(4)

Cognitive & Perceptual Effects

Cognitive(2)

Pharmacology

Detection Methods

Standard Drug Panel Inclusion

Urine Detection

Blood and Saliva Detection

Hair Follicle Detection

Confirmatory Testing

Reagent Testing

Interactions

History

Harm Reduction

General Principles

Ibotenic acid-Specific Considerations

Toxicity & Safety

Overdose Information

Tolerance

Legal Status

Experience Reports (2)

Tips (3)

See Also

References (4)

Frequently Asked Questions